<SEC-DOCUMENT>0001654954-21-005345.txt : 20210510
<SEC-HEADER>0001654954-21-005345.hdr.sgml : 20210510
<ACCEPTANCE-DATETIME>20210510160043
ACCESSION NUMBER:		0001654954-21-005345
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210510
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210510
DATE AS OF CHANGE:		20210510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celcuity Inc.
		CENTRAL INDEX KEY:			0001603454
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38207
		FILM NUMBER:		21906946

	BUSINESS ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 100
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446
		BUSINESS PHONE:		763-392-0767

	MAIL ADDRESS:	
		STREET 1:		16305 36TH AVENUE N
		STREET 2:		SUITE 100
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55446

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celcuity LLC
		DATE OF NAME CHANGE:	20140324
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>celc-20211231.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Blueprint from Issuer Direct Corp.--><!--Copyright 2019 Issuer Direct Corporation--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:i="http://www.xbrl.org/2003/instance" xmlns:celc="http://www.celcuity.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:enum="http://xbrl.org/2014/extensible-enumerations" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
   <head><title>ISDR Blueprint iXBRL Document</title><meta content="text/html; charset=UTF-8" http-equiv="Content-Type" />

   </head>
<body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric id="id5WvIw0vStwmgV" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityCentralIndexKey">0001603454</ix:nonNumeric>
<ix:nonNumeric id="id5WvIw0vStwmgT" contextRef="From-2021-05-10to2021-05-10" name="dei:AmendmentFlag" format="ixt:booleanfalse">false</ix:nonNumeric>
</ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="celc-20211231.xsd"/></ix:references><ix:resources><i:context id="From-2021-05-10to2021-05-10">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001603454</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-05-10</i:startDate>
<i:endDate>2021-05-10</i:endDate>
</i:period>
</i:context>
</ix:resources></ix:header></div>

<div style="margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 4px solid #000000; border-bottom: 1px solid #000000;text-align: center">
<!--style header--><br /><br /></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
UNITED STATES</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SECURITIES AND EXCHANGE COMMISSION</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Washington, D.C. 20549</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 16px">
FORM <ix:nonNumeric id="id8d3ea593f25f44988f1d424ece234f01" contextRef="From-2021-05-10to2021-05-10" name="dei:DocumentType">8-K</ix:nonNumeric></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CURRENT REPORT</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Pursuant to Section&#xA0;13 or 15(d) of the</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Securities Exchange Act of 1934</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Date of Report (Date of earliest event reported): <ix:nonNumeric id="id38ebee2d38484d3fb84e31f9b231214b" contextRef="From-2021-05-10to2021-05-10" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen">May 10,
2021</ix:nonNumeric></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 16px">
<ix:nonNumeric id="idd392eb89e618452ea4321a0ca8bd152d" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityRegistrantName">Celcuity Inc.</ix:nonNumeric></span></div>
<div><span style="font-family: Times New Roman; font-size: 10">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Exact name of Registrant as Specified in its Charter)</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px"><span style="font-size: 5px">
&#xA0;</span>&#xA0;&#xA0;</span></div>
<div>
<table style="width: 100%; font-family: Times New Roman; font-size: 13px" cellspacing="0" cellpadding="0">

<tbody><tr>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="idcac1cef5457f4bc98f1e50fdd926f8bf" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="id216f1b4bcd094b53a610cd65437fcdbc" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityFileNumber">001-38207</ix:nonNumeric></span></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="idba305b04df154ab68c3ad95fa0223f0d" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityTaxIdentificationNumber">82-2863566</ix:nonNumeric></span></div>
</td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(State or Other Jurisdiction</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
of Incorporation)</span></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Commission</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
File Number)</span></div>
</td>
<td style="vertical-align: bottom; width: 1%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(IRS Employer</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Identification No.)</span></div>
</td>
</tr>

</tbody></table>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="idc1bf0162698d45e89771edc0de961865" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityAddressAddressLine1">16305 36th Avenue North</ix:nonNumeric>; <ix:nonNumeric id="id7f0bbb68ddd94eafbf2b9839066c4e66" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="id8935811a425743528241337403e4bcc8" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityAddressCityOrTown">Minneapolis</ix:nonNumeric>, <ix:nonNumeric id="idc368b681b98d42b5857393e939320c69" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">Minnesota</ix:nonNumeric> <ix:nonNumeric id="id6f864f69f877487b967c8f4436ba5774" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityAddressPostalZipCode">55446</ix:nonNumeric></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Address of Principal Executive Offices and Zip Code)</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(<ix:nonNumeric id="id994ae2b311d944db840c7bb95e4d20d8" contextRef="From-2021-05-10to2021-05-10" name="dei:CityAreaCode">763</ix:nonNumeric>) <ix:nonNumeric id="id11a516a79db14f708678194dd8ab911b" contextRef="From-2021-05-10to2021-05-10" name="dei:LocalPhoneNumber">392-0767</ix:nonNumeric></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Registrant&#x2019;s telephone number, including area
code)</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Not Applicable</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
(Former Name or Former Address, if Changed Since Last
Report)</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px"><span style="">
<ix:nonNumeric id="idbf585ba451634ad98b650099158fd4d1" contextRef="From-2021-05-10to2021-05-10" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> Written communications pursuant to Rule&#xA0;425
under the Securities Act (17 CFR 230.425)</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px"><span style="color: #000000">
<ix:nonNumeric id="idaa8f0c2f9f0c4a3282333703556d460d" contextRef="From-2021-05-10to2021-05-10" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> <span style="color: #000000">Soliciting material
pursuant to Rule&#xA0;14a-12 under the Exchange Act (17 CFR
240.14a-12)</span></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px"><span style="color: #000000">
<ix:nonNumeric id="ida06877f7e79c4b1db62b8326bf8576ed" contextRef="From-2021-05-10to2021-05-10" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> <span style="color: #000000">Pre-commencement
communications pursuant to Rule&#xA0;14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</span> &#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px"><span style="color: #000000">
<ix:nonNumeric id="id6dd4d1d1339d4e588f99c18d975bf585" contextRef="From-2021-05-10to2021-05-10" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></span> <span style="color: #000000">Pre-commencement
communications pursuant to Rule&#xA0;13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</span></span></div>
<div><span style="font-family: Times New Roman; font-size: 10">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-family: Times New Roman; font-size: 13px">Securities
registered pursuant to Section 12(b) of the Act:</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div>
<table style="width: 100%; font-family: Times New Roman; font-size: 13px" cellspacing="0" cellpadding="0">

<tbody><tr>
<td style="vertical-align: bottom; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
Title of each class</span></div>
</td>
<td style="vertical-align: bottom; width: 29%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
Trading Symbol(s)</span></div>
</td>
<td style="vertical-align: bottom; width: 37%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
Name of each exchange on which registered</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: middle; width: 33%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="iddaa765a8e16b4a8a8cf68f7793ae95c1" contextRef="From-2021-05-10to2021-05-10" name="dei:Security12bTitle">Common Stock, $0.001 par value per share</ix:nonNumeric></span></div>
</td>
<td style="vertical-align: middle; width: 29%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
<ix:nonNumeric id="id490b6834f3a6453ab1390a5a9be5dea0" contextRef="From-2021-05-10to2021-05-10" name="dei:TradingSymbol">CELC</ix:nonNumeric></span></div>
</td>
<td style="vertical-align: middle; width: 37%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="color: #000000; font-family: Times New Roman; font-size: 13px">
The <ix:nonNumeric id="ided17949e6049454fa25612eb79aba4af" contextRef="From-2021-05-10to2021-05-10" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Stock Market LLC</span></div>
</td>
</tr>

</tbody></table>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (&#xA7;
230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#xA7; 240.12b-2 of this chapter).</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: right">
<span style="font-family: Times New Roman; font-size: 13px">Emerging
growth company <span style="color: #000000"><ix:nonNumeric id="id6ebc30a642014c45aa0242b808410dee" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></span></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. <span style="color: #000000"><ix:nonNumeric id="idc9177750db2d4c359b2ffb45dc330898" contextRef="From-2021-05-10to2021-05-10" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox">&#x2612;</ix:nonNumeric></span></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: right">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 8px; border-top: 1px solid #000000; border-bottom: 4px solid #000000;text-align: center">
<!--style footer--><br /><br /></div>

<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="display: table; margin-left: 3px">
<div style="display: table-row">
<div style="display: table-cell; width: 99px"><span style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><span style="font-size: 13px">
Item 2.02.</span>&#xA0;&#xA0;<br /><br /></span></div>
<div style="display: table-cell;text-align: left"><span style="font-size: 13px; font-weight: bold; font-family: Times New Roman">Results
of Operations and Financial Condition.</span></div>
</div>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 48px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">On May
10, 2021, Celcuity Inc. (the &#x201C;<span style="text-decoration: underline">Company</span>&#x201D;) issued a press
release regarding the Company&#x2019;s financial results for the
first quarter ended March 31, 2021. A copy of the Company&#x2019;s
press release is furnished as Exhibit 99.1 to this report and is
incorporated herein by reference.</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 48px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px"><span style="color: #000000">The information in this Item 2.02, including the
accompanying exhibit, is being furnished and shall not be deemed
&#x201C;filed&#x201D; for the purposes of Section&#xA0;18 of the
Securities Exchange Act of 1934, as amended (the &#x201C;Exchange
Act&#x201D;), or otherwise subject to the liabilities of that
Section. The information in this Item 2.02 shall not be
incorporated by reference into any filing pursuant to the
Securities Act of 1933, as amended, or the Exchange Act, regardless
of any general incorporation language in such
filing.</span><span style="color: #000000">&#xA0;</span></span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="display: table; margin-left: 3px">
<div style="display: table-row">
<div style="display: table-cell; width: 99px"><span style="font-weight: bold; font-family: Times New Roman; font-size: 13px"><span style="font-size: 13px">
Item&#xA0;9.01.</span>&#xA0;&#xA0;&#xA0;<br /><br /></span></div>
<div style="display: table-cell;text-align: left"><span style="font-size: 13px; font-weight: bold; font-family: Times New Roman">Financial
Statements and Exhibits.</span></div>
</div>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div>
<table style="width: 100%; font-family: Times New Roman; font-size: 13px" cellspacing="0" cellpadding="0">

<tbody><tr>
<td style="vertical-align: bottom; width: 5%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(d)</span></div>
</td>
<td style="vertical-align: bottom; width: 95%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Exhibits</span></div>
</td>
</tr>

</tbody></table>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div>
<table style="width: 100%; font-family: Times New Roman; font-size: 13px" cellspacing="0" cellpadding="0">

<tbody><tr>
<td style="vertical-align: bottom; width: 10%; border-bottom: 2px solid #000000">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Exhibit</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Number</span></div>
</td>
<td style="vertical-align: bottom; width: 2%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 88%; border-bottom: 2px solid #000000">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Description</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: bottom; width: 10%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: bottom; width: 90%" colspan="2">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: top; width: 10%;">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="color: rgb(0, 0, 0);"><a href="celc_ex991.htm"><span style="font-family: Times New Roman; font-size: 13px;">99.1</span></a></span></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: top; width: 88%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Press
release dated May 10, 2021</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: top; width: 10%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">104</span></div>
</td>
<td style="vertical-align: top; width: 2%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: top; width: 88%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Cover
Page Interactive Data File (embedded within the Inline XBRL
document)</span></div>
</td>
</tr>

</tbody></table>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>

<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: justify">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: center">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
SIGNATURES</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Date:
May 10, 2021&#xA0;</span></div>
<div><span style="font-family: Times New Roman; font-size: 10">&#xA0;</span></div>
<div>
<table style="width: 100%; font-family: Times New Roman; font-size: 13px" cellspacing="0" cellpadding="0">

<tbody><tr>
<td style="vertical-align: middle; width: 49%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: middle; width: 51%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
CELCUITY INC.</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: middle; width: 49%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: middle; width: 51%; border-bottom: 2px solid #000000">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">By: /s/
Brian F. Sullivan</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: middle; width: 49%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: middle; width: 51%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Brian
F. Sullivan</span></div>
</td>
</tr>
<tr>
<td style="vertical-align: middle; width: 49%">
<div><span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
</td>
<td style="vertical-align: middle; width: 51%">
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">Chairman
and Chief Executive Officer &#xA0; &#xA0;</span></div>
</td>
</tr>

</tbody></table>
</div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>
<div><span style="font-family: Times New Roman; font-size: 10">&#xA0;</span></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;text-align: left">
<span style="font-family: Times New Roman; font-size: 13px">&#xA0;</span></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>celc_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2021 Issuer Direct Corporation -->
<title>celc_ex991</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Exhibit
99.1</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="celc_ex991000.jpg"></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Celcuity Inc. Reports First Quarter 2021 Financial Results and
Provides Corporate Update</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
-<br></font></div>
<div style="text-align: justify; display: table-cell"><font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Entered into worldwide licensing agreement with Pfizer to develop
and commercialize gedatolisib, a first-in-class PI3K/mTOR
inhibitor, in clinical development for breast cancer</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
-<br></font></div>
<div style="text-align: justify; display: table-cell"><font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Announced encouraging preliminary data from a Phase 1b trial of
gedatolisib plus Ibrance&#xAE; and endocrine therapy for patients
with ER+/HER2- metastatic breast cancer, in which gedatolisib
showed a potentially differentiated safety and tolerability
profile</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
-<br></font></div>
<div style="text-align: justify; display: table-cell"><font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Secured additional financing to strengthen cash position and
provide funding for expanded clinical development
activities</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
-<br></font></div>
<div style="text-align: justify; display: table-cell"><font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Entered into clinical trial collaboration agreements with leading
cancer research centers, Novartis, Pfizer, and Puma to evaluate the
efficacy of targeted therapies in patients selected with
Celcuity&#x2019;s CELsignia Multi-Pathway Activity Test</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
-<br></font></div>
<div style="text-align: justify; display: table-cell"><font style="font-style: italic; font-family: Times New Roman; font-size: 13px">
Management to host webcast and conference call today, May 10, at
4:30 p.m. ET / 1:30 p.m. PT</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px"><font style="font-weight: bold">
MINNEAPOLIS, May 10, 2021</font> &#x2014; Celcuity Inc. (Nasdaq:
CELC), a clinical-stage biotechnology company pursuing an
integrated companion diagnostic (CDx) and therapeutic strategy for
treating patients with cancer, today announced financial results
for the first quarter ended March 31, 2021 and summarized recent
business progress.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">"Celcuity
took a transformational strategic step in April when we entered
into a global licensing agreement with Pfizer to obtain exclusive
rights to develop and commercialize gedatolisib, a pan-PI3K/mTOR
inhibitor, in clinical development to treat patients with
ER+/HER2-negative advanced or metastatic breast cancer,&#x201D; said
Brian Sullivan, CEO and co-founder of Celcuity. &#x201C;Celcuity is
planning to initiate, subject to feedback from the FDA, a Phase 2/3
clinical trial evaluating gedatolisib in combination with
palbociclib and an endocrine therapy in the first half of 2022. We
have a highly experienced drug development team and the financial
resources in place to advance the gedatolisib program and are
excited by the opportunity to utilize our CELsignia cellular
analysis platform to support the development of a potential
first-in-class targeted cancer therapy like
gedatolisib.&#x201D;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
First Quarter 2021 Business Highlights and Other Recent
Developments</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In January,
Celcuity entered a collaboration with Sarah Cannon Research
Institute and Pfizer Inc. to conduct an open-label Phase 2 clinical
trial. This trial will evaluate the efficacy and safety of two
Pfizer targeted therapies, VIZIMPRO<font style="font-size: 70%; vertical-align: top">&#xAE;</font>, a pan-HER
inhibitor, and XALKORI<font style="font-size: 70%; vertical-align: top">&#xAE;</font>, a c-Met
inhibitor, in patients with previously treated metastatic
HER2-negative breast cancer selected with Celcuity&#x2019;s
CELsignia Multi-Pathway Activity Test. Celcuity believes there is
significant clinical interest in finding new diagnostic tests and
targeted therapies for patients with metastatic HER2-negative
breast cancer whose disease progressed on prior therapies. Patient
enrollment is expected to begin in the second or third quarter of
2021 with interim results in the second half of 2022.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Celcuity raised
approximately $43.0 million of gross proceeds from financings in
the first quarter of 2021 and April 2021.</font></div>
</div>
</div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">o</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In late February,
Celcuity completed a successful follow-on public offering that
raised gross proceeds of approximately $27.6 million.</font></div>
</div>
</div>
<div style="margin-left: 48px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-family: Times New Roman; font-size: 13px">o</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In early April,
Celcuity entered into a debt financing agreement with Innovatus
Life Sciences Lending Fund I, LP to provide up to $25.0 million in
term loans with the first tranche of $15.0 million funded at
closing. Celcuity will be able to draw on two additional tranches
of $5.0 million each upon the achievement of certain clinical trial
and financing milestones.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="color: #000000; font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">In March, Celcuity entered into a clinical trial
collaboration with MD Anderson, Novartis, and Puma Biotechnology to
evaluate the efficacy and safety of Novartis&#x2019; targeted
therapy TABRECTA</font><font style="font-size: 70%; vertical-align: top; color: #000000">&#xAE;</font>
<font style="color: #000000">and Puma&#x2019;s
NERLYNX</font><font style="font-size: 70%; vertical-align: top; color: #000000">&#xAE;</font>
<font style="color: #000000">in patients with metastatic
HER2-negative breast cancer selected by Celcuity&#x2019;s CELsignia
Multi-Pathway Activity Test. This is Celcuity&#x2019;s second
clinical trial to treat patients diagnosed with hyperactive HER2
and c-Met signaling breast cancers with matching targeted therapies
and Celcuity now has five clinical trial collaborations in
place.</font></font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In April, Celcuity
entered a worldwide licensing agreement with Pfizer for the
exclusive right to develop and commercialize gedatolisib.
Gedatolisib is in Phase 1b clinical development for the treatment
of patients with ER+/HER2-negative advanced or metastatic breast
cancer. Celcuity announced preliminary data for the 103 patients
enrolled in the expansion portion of the ongoing Phase 1b clinical
trial evaluating gedatolisib, plus Ibrance and endocrine therapy.
As of the January 11, 2021 data cut-off, 53 of the 88 evaluable
patients (60%) had an objective response. Gedatolisib was also
generally well tolerated, with the majority of treatment-related
adverse events (TRAE) being Grade 1 or 2. The most common Grade 3
or 4 TRAEs related to gedatolisib were stomatitis and rash.
Celcuity plans to meet with the FDA later this year to discuss its
clinical development plans for gedatolisib.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">In April, Celcuity
presented results of studies evaluating gedatolisib, inavolisib (a
PI3K-<font style="font-style: italic">a</font> inhibitor), and
navitoclax (a BCL inhibitor) in breast and ovarian patient tumors
in two posters at the American Association for Cancer Research
(AACR) Annual Meeting. The results showed that gedatolisib
inhibited nine times more signaling test activity in tumors with
hyperactive RAS network signaling, on average, than inavolisib,
when evaluated at equal concentrations with the CELsignia test.
Gedatolisib at one-fifth the concentration of inavolisib (30 nM vs.
150 nM), inhibited five times more signaling activity as quantified
by the CELsignia test. Data also showed that synergistic
cooperation between PI3K/mTOR and BCL signaling was detected,
suggesting potential patient benefit of combining gedatolisib with
a BCL inhibitor.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
First Quarter 2021 Financial Results</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Unless
otherwise stated, all comparisons are for the first quarter ended
March 31, 2021, compared to the first quarter ended March 31,
2020.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Total
operating expenses were $2.79 million for the first quarter of
2021, compared to $2.31 million for the first quarter of
2020.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Research
and development (R&amp;D) expenses were $2.24 million for the first
quarter of 2021, compared to $1.85 million for the first quarter of
2020. The approximately $0.39 million increase during the first
three months of fiscal year 2021, compared to the first three
months of fiscal year 2020, resulted from a $0.06 million increase
in compensation related expenses, which included a decrease of
approximately $0.04 million of non-cash stock-based compensation
expense. In addition, other research and development expenses
increased $0.33 million due to clinical validation and laboratory
studies, and operational and business development
activities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">General
and administrative (G&amp;A) expenses were $0.56 million for the
first quarter of 2021, compared to $0.46 million for the first
quarter of 2020. The approximately $0.09 million increase during
the first three months of fiscal year 2021, compared to the first
three months of fiscal year 2020, resulted primarily from a $0.08
million increase in professional fees associated with being a
public company and director and officer insurance.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Net
loss for the first quarter of 2021 was $2.79 million, or $0.25 per
share, compared to a net loss of $2.25 million, or $0.22 per share,
for the first quarter of 2020. Non-GAAP adjusted net loss for the
first quarter of 2021 was $2.34 million, or $0.21 per share,
compared to non-GAAP adjusted net loss of $1.78 million, or $0.17
per share, for the first quarter of 2020. Non-GAAP adjusted net
loss excludes stock-based compensation expense. Because this item
has no impact on Celcuity&#x2019;s cash position, <font style="color: #231F20">management believes non-GAAP adjusted net loss
better enables Celcuity to focus on cash used in operations.</font>
For a reconciliation of financial measures calculated in accordance
with generally accepted accounting principles in the United States
(GAAP) to non-GAAP financial measures, please see the financial
tables at the end of this press release.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Net
cash used in operating activities for the first quarter of 2021 was
$2.52 million, compared to $1.83 million for the first quarter of
2020.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">At
March 31, 2021, Celcuity had cash and cash equivalents of $34.9
million, compared to cash and cash equivalents of $11.6 million at
December 31, 2020. On April 8, 2021, Celcuity paid an upfront
license fee of $5.0 million in conjunction with the Pfizer
gedatolisib license agreement and received $14.5 million of net
proceeds from a debt financing agreement. Taking into account these
two events subsequent to the end of the first quarter, Celcuity has
approximately $44.0 million of cash-on-hand.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Anticipated Milestones</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Celcuity
expects to do the following over the next twelve
months:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25A0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Announce additional
clinical trial collaborations in the first half of 2021 utilizing
the CELsignia platform.</font></div>
</div>
</div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25A0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Initiate Phase 2/3
clinical trial for gedatolisib in breast cancer in the first half
of 2022 pending discussions with the FDA regarding the clinical
development pathway.</font></div>
</div>
</div>
<div style="margin-left: 24px; display: table">
<div style="display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25A0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-family: Times New Roman; font-size: 13px">Provide interim
results from the FACT-1 and FACT-2 trials in late 2021 or early
2022.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Webcast and Conference Call Information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">The
Celcuity management team will host a webcast/conference call at
4:30 p.m. ET today to discuss the first quarter financial results
and provide a corporate update. To participate in the
teleconference, domestic callers should dial 1-877-407-8035 and
international callers should dial <font style="color: #000000">201-689-8035</font>.&#xA0;A live webcast
presentation can also be accessed using this weblink: <font style="text-decoration: underline; color: #0563C1">https://www.webcaster4.com/Webcast/Page/2678/40988</font>.
A replay of the webcast will be available on the Celcuity website
following the live event.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #231F20; font-family: Times New Roman; font-size: 13px">
About Celcuity</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Celcuity
is a clinical-stage biotechnology company seeking to extend the
lives of cancer patients by pursuing an integrated companion
diagnostic and therapeutic strategy. Our CELsignia companion
diagnostic (CDx) platform is uniquely able to analyze live patient
tumor cells to identify new groups of cancer patients likely to
benefit from targeted therapies. This enables our CELsignia CDx
platform to support advancement of new indications for already
approved targeted therapies. Our therapeutic efforts are focused on
in-licensing and developing molecularly targeted therapies that
address the same cancer driver our companion diagnostics can
identify. By pursuing an integrated companion diagnostic and
therapeutic strategy, we believe we are uniquely positioned to
achieve our goal of helping cancer patients receive the therapeutic
best suited to treat their cancer driver. Celcuity is headquartered
in Minneapolis. Further information about Celcuity can be found at
<font style="text-decoration: underline; color: #0000FF">www.celcuity.com</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; color: #231F20; font-family: Times New Roman; font-size: 13px">
Forward-Looking Statements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">This
press release contains statements that constitute "forward-looking
statements." In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "expects,"
"plans," "anticipates," "believes," "estimates," "predicts,"
"potential," "intends" or "continue," and other similar expressions
that are predictions of or indicate future events and future
trends, or the negative of these terms or other comparable
terminology. Forward-looking statements are subject to numerous
conditions, many of which are beyond the control of Celcuity, which
include, but are not limited to, the unknown impact of the COVID-19
pandemic on Celcuity's business and those other risks set forth in
the Risk Factors section in Celcuity's Annual Report on Form 10-K
for the year ended December 31, 2020 filed with the Securities and
Exchange Commission on February 16, 2021 and in Exhibit 99.4 to
Celcuity's Current Report on Form 8-K filed with the Securities and
Exchange Commission on April 8, 2021. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof. Celcuity undertakes no obligation
to update these statements for revisions or changes after the date
of this press release, except as required by law.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-weight: bold; font-family: Times New Roman; font-size: 13px">
Contacts:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Celcuity
Inc.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Brian
Sullivan, <font style="text-decoration: underline; color: #0563C1">bsullivan@celcuity.com</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Vicky
Hahne, <font style="text-decoration: underline; color: #0563C1">vhahne@celcuity.com</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Westwicke
ICR</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">Robert
Uhl, <font style="text-decoration: underline; color: #0000FF">robert.uhl@westwicke.com</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">(619)
228-5886</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td colspan="3" rowspan="1" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
Celcuity Inc.</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
&#xA0;Condensed Balance Sheets</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:94%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:3%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:1px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 1px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
March 31,</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
2021</font></div>
</font><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 1px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
December 31,</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
2020</font></div>
</font><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
&#xA0;(unaudited)</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; font-size: 11px;">
<div><font style="font-family: Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Current Assets:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Cash
and cash equivalents</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">34,936,902</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">11,637,911</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Deposits</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">22,009</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">22,009</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Deferred
transaction costs</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">13,719</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Payroll
tax receivable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">190,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">190,000</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Prepaid
assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">551,345</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">317,040</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total current assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">35,713,975</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">12,166,960</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Property
and equipment, net</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">466,484</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">558,876</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Operating
lease right-of-use assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">186,602</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">230,911</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total Assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:5%;border-bottom:double 4px #000000;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:75%;border-bottom:double 4px #000000;">36,367,061</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:5%;border-bottom:double 4px #000000;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:75%;border-bottom:double 4px #000000;">12,956,747</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Liabilities and Stockholders' Equity:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Current Liabilities:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Accounts
payable</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">318,213</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">217,377</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Finance
lease liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,819</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">5,810</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Operating
lease liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">185,656</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">187,518</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Accrued
expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">660,849</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">774,612</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total current liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,170,537</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,185,317</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Finance
lease liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">6,841</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">8,299</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Operating
lease liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">15,139</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">60,861</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total Liabilities</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,192,517</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">1,254,477</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total Stockholders' Equity</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">35,174,544</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">11,702,270</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Total Liabilities and Stockholders' Equity</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:5%;border-bottom:double 4px #000000;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:75%;border-bottom:double 4px #000000;">36,367,061</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:5%;border-bottom:double 4px #000000;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;font-size:13px;display:inline-block;font-weight:bold;width:75%;border-bottom:double 4px #000000;">12,956,747</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;font-weight:bold;padding-bottom:4px;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Celcuity Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Condensed Statements of Operations</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
(unaudited)</font></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;"></div>
<div style="null"><font>&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:1px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom:1px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:90%;border-bottom:solid 1px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
Three Months Ended</font></div>
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
March 31,</font></div>
</font><font style="text-align: left; padding-bottom:1px;width:5%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:1px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:1px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 1px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
2021</font></div>
</font><font style="text-align: left; padding-bottom:1px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom:1px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;border-bottom:solid 1px #000000;display:inline-block;">
<div><font style="font-weight:bold;font-size:13px;font-family:Times New Roman;color:#000000;">
2020</font></div>
</font><font style="text-align: left; padding-bottom:1px;width:10%;vertical-align:bottom;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Operating expenses:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Research
and development</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">2,236,342</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">1,847,414</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;General
and administrative</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">555,428</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">463,399</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Total
operating expenses</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,791,770</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">2,310,813</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Loss
from operations</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,791,770</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,310,813</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Other
income (expense)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Interest
expense</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(24</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(33</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Interest
income</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">388</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">63,851</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:24px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Loss
on sale of fixed assets</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(263</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Other
income, net</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">101</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">63,818</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Net loss before income taxes</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,791,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,246,995</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Income
tax benefits</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">-</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
&#xA0;Net loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,791,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,246,995</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">&#xA0;Net
loss per share, basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.22</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Weighted
average common shares outstanding, basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">11,072,097</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">10,253,988</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #231F20; font-weight: bold; font-family: Times New Roman; font-size: 13px">
Cautionary Statement Regarding Non-GAAP Financial
Measures</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="color: #231F20; font-family: Times New Roman; font-size: 13px">
This press release contains references to non-GAAP adjusted net
loss and non-GAAP adjusted net loss per share. Management believes
these non-GAAP financial measures are useful supplemental measures
for planning, monitoring, and evaluating operational performance as
they exclude stock-based compensation expense from net loss and net
loss per share. Management excludes this item because it does not
impact Celcuity&#x2019;s cash position, which management believes
better enables Celcuity to focus on cash used in operations.
However, non-GAAP adjusted net loss and non-GAAP adjusted net loss
per share are not recognized measures under GAAP and do not have a
standardized meaning prescribed by GAAP. As a result,
management&#x2019;s method of calculating non-GAAP adjusted net loss
and non-GAAP adjusted net loss per share may differ materially from
the method used by other companies. Therefore, non-GAAP adjusted
net loss and non-GAAP adjusted net loss per share may not be
comparable to similarly titled measures presented by other
companies. Investors are cautioned that non-GAAP adjusted net loss
and non-GAAP adjusted net loss per share should not be construed as
alternatives to net loss, net loss per share or other statements of
operations data (which are determined in accordance with GAAP) as
an indicator of Celcuity&#x2019;s performance or as a measure of
liquidity and cash flows.</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; page-break-after: always; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
<div id="hdr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Celcuity Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
Reconciliation of GAAP Net Loss to Non-GAAP Adjusted Net Loss
and</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px;"><font style="font-weight: bold; color: #000000; font-family: Times New Roman; font-size: 13px">
GAAP Net Loss Per Share to Non-GAAP Adjusted Net Loss Per
Share</font></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;"></div>
<div style="margin-left: 0px; margin-right: 0px; text-indent: 0px;"></div>
<div style="null"><font>&#xA0;</font></div>
<div>
<table cellpadding="0" cellspacing="0" style="margin-right:0px;width:100%;font-size:inherit;font-family:inherit;margin-left:0px;">
<tr>
<td rowspan="1" style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:1px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align:bottom;width:24%;">
<div><font style="text-align: left; padding-bottom: 1px; width: 5%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; border-bottom: 1px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
Three Months Ended March 31,</font></div>
</font><font style="text-align: left; padding-bottom: 1px; width: 5%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;padding-bottom:1px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 1px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
2021</font></div>
</font><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; border-bottom: 1px solid rgb(0, 0, 0); display: inline-block; font-size: 11px;">
<div><font style="font-weight: bold; font-family: Times New Roman; color: rgb(0, 0, 0);">
2020</font></div>
</font><font style="text-align: left; padding-bottom: 1px; width: 10%; vertical-align: bottom; display: inline-block; font-size: 11px;">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font><font style="text-align: center; vertical-align:bottom;width:80%;display:inline-block;">
<div><font style="font-size:13px;font-family:Times New Roman;">&#xA0;</font></div>
</font><font style="text-align: left; vertical-align:bottom;width:10%;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">GAAP
net loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,791,668</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,246,995</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:36px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Adjustments:</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Stock-based
compensation</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:36px;margin-right:0px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">Research and development</font> <font style="font-size: 70%; vertical-align: top; color: #000000">(1)</font></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">255,181</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">293,116</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:36px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px"><font style="color: #000000">General and administrative</font> <font style="font-size: 70%; vertical-align: top; color: #000000">(2)</font></font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">193,917</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">171,533</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non-GAAP
adjusted net loss</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(2,342,570</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(1,782,346</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">GAAP
net loss per share - basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.25</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">$</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">(0.22</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:1px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Adjustment
to net loss (as detailed above)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.04</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;border-bottom:solid 1px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">0.05</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:1px;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;padding-bottom:4px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Non-GAAP
adjusted net loss per share</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(0.21</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:5%;font-family:Times New Roman;font-size:13px;">$</font><font style="text-align: right; color:#000000;border-bottom:double 4px #000000;vertical-align:bottom;display:inline-block;width:75%;font-family:Times New Roman;font-size:13px;">(0.17</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;padding-bottom:4px;font-size:13px;">)</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#cceeff;">
<td style="vertical-align:bottom;width:76%;">
<div style="text-align: left; text-indent:0px;margin-right:0px;margin-left:0px;"><font style="color: #000000; font-family: Times New Roman; font-size: 13px">Weighted
average common shares outstanding, basic and diluted</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">11,072,097</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:5%;font-size:13px;">&#xA0;</font><font style="text-align: right; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:75%;font-size:13px;">10,253,988</font><font style="text-align: left; color:#000000;font-family:Times New Roman;vertical-align:bottom;display:inline-block;width:10%;font-size:13px;">&#xA0;</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td style="vertical-align:bottom;width:76%;">
<div style="margin-left:0px;"><font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
<td style="vertical-align:bottom;width:12%;">
<div><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:5%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: right; vertical-align:bottom;width:75%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font><font style="text-align: left; vertical-align:bottom;width:10%;font-size:13px;font-family:Times New Roman;display:inline-block;">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">(1) To
reflect a non-cash charge to operating expense for Research and
Development stock-based compensation.</font></div>
</td>
</tr><tr style="background-color:#ffffff;">
<td colspan="3" style="vertical-align:bottom;width:100%;">
<div style="text-align: left; margin-left: 0px; text-indent: 0px; margin-right: 0px;"><font style="font-size:13px;font-family:Times New Roman;color:#000000;">(2) To
reflect a non-cash charge to operating expense for General and
Administrative stock-based compensation.</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
<div><font style="font-family: Times New Roman; font-size: 10">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr">
<div style="text-align: left; width: 100%; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<font style="font-family: Times New Roman; font-size: 13px">&#xA0;</font></div>
</div>
<div id="pb" style="text-align: center; margin-left: 0px; margin-right: 0px; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000">
<!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>celc_ex991000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 celc_ex991000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( .$# 2(  A$! Q$!_\0
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MO5/#-G/I_A;2K.Y7;/!:QQR+G.&"C(J*OP+F=V53^)V6AYSX^_Y+%X/^L?\
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M0:YCQ;X%T?QA$IOD:*ZC&V.YBX=1Z'L1[&N,'PG\168\K3O&EU';CHIWKC\
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A._LZ-HLBU!)"<GIGG!ZC/8UT%%%83^)FT=D%%%%2,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>celc-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Issuer Direct Blueprint 2.0-->
<!--Based on XBRL 2.1-->
<!--Created on:5/9/21 11:58:29 PM-->
<schema targetNamespace="http://www.celcuity.com/20211231" elementFormDefault="qualified" attributeFormDefault="unqualified" xmlns:celc="http://www.celcuity.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:enum="http://xbrl.org/2014/extensible-enumerations" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/2001/XMLSchema">
	<annotation>
		<appinfo>
			<link:roleType roleURI="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" id="Document-DocumentandEntityInformation">
				<link:definition>1001001 - Document - Document and Entity Information</link:definition>
				<link:usedOn>link:presentationLink</link:usedOn>
				<link:usedOn>link:calculationLink</link:usedOn>
				<link:usedOn>link:definitionLink</link:usedOn>
			</link:roleType>
			<link:linkbaseRef xlink:type="simple" xlink:href="celc-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
			<link:linkbaseRef xlink:type="simple" xlink:href="celc-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
		</appinfo>
	</annotation>
	<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
	<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
	<import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
	<import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
	<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
	<xs:element name="DocumentAndEntityInformationAbstract" id="celc_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" abstract="true" nillable="true" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>celc-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Issuer Direct Blueprint 2.0-->
<!--Based on XBRL 2.1-->
<!--Created on:5/9/21 11:58:29 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
	<link:roleRef roleURI="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" xlink:href="celc-20211231.xsd#Document-DocumentandEntityInformation" xlink:type="simple" />
	<link:calculationLink xlink:type="extended" xlink:role="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>celc-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Issuer Direct Blueprint 2.0-->
<!--Based on XBRL 2.1-->
<!--Created on:5/9/21 11:58:29 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" xlink:type="simple" />
	<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
	<link:roleRef roleURI="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" xlink:href="celc-20211231.xsd#Document-DocumentandEntityInformation" xlink:type="simple" />
	<link:definitionLink xlink:type="extended" xlink:role="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>celc-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Issuer Direct Blueprint 2.0-->
<!--Based on XBRL 2.1-->
<!--Created on:5/9/21 11:58:29 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
	<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
	<link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
		<link:loc xlink:type="locator" xlink:href="celc-20211231.xsd#celc_DocumentAndEntityInformationAbstract" xlink:label="loc_celc_DocumentAndEntityInformationAbstract" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="celc_DocumentAndEntityInformationAbstract_1_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="celc_DocumentAndEntityInformationAbstract_1_lbl" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="celc_DocumentAndEntityInformationAbstract_2_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="celc_DocumentAndEntityInformationAbstract_2_lbl" xml:lang="en-US">Document And Entity Information Abstract</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" />
		<link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
		<link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
	</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>celc-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Issuer Direct Blueprint 2.0-->
<!--Based on XBRL 2.1-->
<!--Created on:5/9/21 11:58:29 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
	<link:roleRef roleURI="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation" xlink:href="celc-20211231.xsd#Document-DocumentandEntityInformation" xlink:type="simple" />
	<link:presentationLink xlink:type="extended" xlink:role="http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation">
		<link:loc xlink:type="locator" xlink:href="celc-20211231.xsd#celc_DocumentAndEntityInformationAbstract" xlink:label="loc_celc_DocumentAndEntityInformationAbstract" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityCentralIndexKey" order="-115" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_AmendmentFlag" order="-112" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_AmendmentDescription" order="-111" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_DocumentType" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_DocumentPeriodEndDate" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityRegistrantName" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityIncorporationStateCountryCode" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityFileNumber" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityTaxIdentificationNumber" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityAddressAddressLine1" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityAddressAddressLine2" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityAddressCityOrTown" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityAddressStateOrProvince" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityAddressPostalZipCode" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_CityAreaCode" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_LocalPhoneNumber" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_WrittenCommunications" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_SolicitingMaterial" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_PreCommencementTenderOffer" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_PreCommencementIssuerTenderOffer" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_Security12bTitle" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_TradingSymbol" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_SecurityExchangeName" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityEmergingGrowthCompany" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_celc_DocumentAndEntityInformationAbstract" xlink:to="loc_dei_EntityExTransitionPeriod" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_dei_AmendmentDescription" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_dei_EntityAddressAddressLine2" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" />
		<link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" />
	</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>celc-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="celc-20211231.xsd" xlink:type="simple"/>
    <context id="From-2021-05-10to2021-05-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001603454</identifier>
        </entity>
        <period>
            <startDate>2021-05-10</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="From-2021-05-10to2021-05-10"
      id="id5WvIw0vStwmgV">0001603454</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="From-2021-05-10to2021-05-10"
      id="id5WvIw0vStwmgT">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="From-2021-05-10to2021-05-10"
      id="id8d3ea593f25f44988f1d424ece234f01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="From-2021-05-10to2021-05-10"
      id="id38ebee2d38484d3fb84e31f9b231214b">2021-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="From-2021-05-10to2021-05-10"
      id="idd392eb89e618452ea4321a0ca8bd152d">Celcuity Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="From-2021-05-10to2021-05-10"
      id="idcac1cef5457f4bc98f1e50fdd926f8bf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="From-2021-05-10to2021-05-10"
      id="id216f1b4bcd094b53a610cd65437fcdbc">001-38207</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="From-2021-05-10to2021-05-10"
      id="idba305b04df154ab68c3ad95fa0223f0d">82-2863566</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="From-2021-05-10to2021-05-10"
      id="idc1bf0162698d45e89771edc0de961865">16305 36th Avenue North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From-2021-05-10to2021-05-10"
      id="id7f0bbb68ddd94eafbf2b9839066c4e66">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From-2021-05-10to2021-05-10"
      id="id8935811a425743528241337403e4bcc8">Minneapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From-2021-05-10to2021-05-10"
      id="idc368b681b98d42b5857393e939320c69">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From-2021-05-10to2021-05-10"
      id="id6f864f69f877487b967c8f4436ba5774">55446</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From-2021-05-10to2021-05-10"
      id="id994ae2b311d944db840c7bb95e4d20d8">763</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From-2021-05-10to2021-05-10"
      id="id11a516a79db14f708678194dd8ab911b">392-0767</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="From-2021-05-10to2021-05-10"
      id="idbf585ba451634ad98b650099158fd4d1">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="From-2021-05-10to2021-05-10"
      id="idaa8f0c2f9f0c4a3282333703556d460d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="From-2021-05-10to2021-05-10"
      id="ida06877f7e79c4b1db62b8326bf8576ed">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="From-2021-05-10to2021-05-10"
      id="id6dd4d1d1339d4e588f99c18d975bf585">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From-2021-05-10to2021-05-10"
      id="iddaa765a8e16b4a8a8cf68f7793ae95c1">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From-2021-05-10to2021-05-10"
      id="id490b6834f3a6453ab1390a5a9be5dea0">CELC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From-2021-05-10to2021-05-10"
      id="ided17949e6049454fa25612eb79aba4af">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="From-2021-05-10to2021-05-10"
      id="id6ebc30a642014c45aa0242b808410dee">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="From-2021-05-10to2021-05-10"
      id="idc9177750db2d4c359b2ffb45dc330898">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139799995299464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 10, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_celc_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001603454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 10,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Celcuity Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-2863566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">16305 36th Avenue North<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minneapolis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">392-0767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CELC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_celc_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information Abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">celc_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>celc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( !2 JE('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  4@*I21]H[YNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>.NE@AZC+98@32$A, G&+$F^+:-HH,6KW]J1AZX3@ 3C&_O/Y
ML^36!&F&B,]Q"!C)8;J9?-<G:<*&'8F"!$CFB%ZG.B?ZW-P/T6O*SWB H,V'
M/B TG*_!(VFK2<,,K,)"9*JU1IJ(FH9XQENSX,-G[ K,&L ./?:40-0"F)HG
MAM/4M7 %S##"Z--W >U"+-4_L:4#[)R<DEM2XSC6XZKD\@X"WIX>7\JZE>L3
MZ=Y@_I6<I%/ #;M,?EUM[W</3#6\$16_JP3?B;7D7-[R]]GUA]]5V _6[=T_
M-KX(JA9^W87Z E!+ P04    "  4@*I2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M !2 JE)&UQ1V:@0  )D1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MG9A=<^(V%(:OM[]"P_2BG4GB#\"0'<(,(4F;V23+!MJ=::<7PA98$UMR)3G
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M>$CHN@D&'[^BB68(1[_BZ*,Z52X6NXPU8>##AY>?$(B@@@C.@Y@QQ:6MB8A
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ %("J4I>*NQS     $P(   L
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MEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0    ( !2
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !2 JE)&UQ1V:@0  )D1   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  4@*I2GZ ;\+$"  #B#   #0              @ &M#   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( !2 JE*7BKL<P    !,"   +
M  "  8D/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( !2 JE(<.&7J/P$  #P"
M   /              "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  4@*I2)!Z;HJT   #X 0  &@              @ '>$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  4@*I299!YDAD!  #/ P
M$P              @ '#$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"   -%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="celc-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="celc-20211231.htm">celc-20211231.htm</File>
    <File>celc-20211231.xsd</File>
    <File>celc-20211231_lab.xml</File>
    <File>celc-20211231_pre.xml</File>
    <File>celc_ex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "celc-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "celc-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "celc-20211231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "celc-20211231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "celc-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "celc",
   "nsuri": "http://www.celcuity.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "celc-20211231.htm",
      "contextRef": "From-2021-05-10to2021-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "1001001 - Document - Document and Entity Information",
     "role": "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "celc-20211231.htm",
      "contextRef": "From-2021-05-10to2021-05-10",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "celc_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document And Entity Information Abstract",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.celcuity.com/20211231",
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.celcuity.com/20211231/role/Document-DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001654954-21-005345-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-21-005345-xbrl.zip
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M2*(D[2P3Z^>*7Z6-"&B@!SRT+;L=6G[@0=3-;2UDS#.<T/7##6P$F(+ETL-
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MX?YG8\D2^HS5D=LR6+"Y/4_!&1/(/P)I+C%JT7(!Q :.'\S? KZ6? 4H2"\
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M\!I+D&Z\=+K9:=C*!?%=OF&</?7?,\%AFNY%G9HT,9(G,R//%^=%+@V(E*,
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MOVZ^A*^@UT$^U132][H^U[VNQ;F]-?VW[]LS^F$4C5WXX?\!4$L! A0#%
M  @ %("J4L9<JI,U$0   7D  !$              ( !     &-E;&,M,C R
M,3$R,S$N:'1M4$L! A0#%     @ %("J4BLYY:UR P  R0L  !$
M     ( !9!$  &-E;&,M,C R,3$R,S$N>'-D4$L! A0#%     @ %("J4B%M
M(_A<!@  +$   !4              ( !!14  &-E;&,M,C R,3$R,S%?;&%B
M+GAM;%!+ 0(4 Q0    ( !2 JE+STZC<D 0  !<O   5              "
M 90;  !C96QC+3(P,C$Q,C,Q7W!R92YX;6Q02P$"% ,4    "  4@*I2T7/(
M=<\I  #E3P( #@              @ %7(   8V5L8U]E>#DY,2YH=&U02P4&
2      4 !0!  0  4DH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
